Orthoson
Develops an injectable implant to restore spinal disc mechanics for people with degenerative disc disease and back pain
Highlights
- New on EvolcAdded 2026-11-01
About Orthoson
Orthoson is developing a micro-invasive injectable bio-structural gel designed to restore the mechanics and environment of intervertebral discs and treat back pain associated with degeneration. Its therapy is in development and is not approved for commercial use.
The company is based at Oxford Science Park in Oxford, UK. Its technology builds on research with the University of Oxford’s Institute of Biomedical Engineering. It raised a £1.8 million seed round in 2019 and completed an £8.9 million Series A round in 2022.
Product: An injectable bio-structural gel implant designed to restore intervertebral disc mechanics and address disc degeneration.
Jobs at Orthoson
Leadership
- Rich Simmonds · Chief Executive OfficerSource: company website
- Constantin Coussios · CTO, Founder and DirectorSource: company website
More biotech & pharma companies
Ottimo Pharma
Clinical-stage biotech developing PD-1/VEGFR2 dual-paratopic antibodies for patients with cancerNew on EvolcOxsonics
Clinical-stage drug delivery company developing SonoTran, an ultrasound platform that boosts anti-cancer drug penetration into solid tumoursNew on EvolcPathios Therapeutics
Develops GPR65-targeting cancer immunotherapies for patients with solid tumorsNew on EvolcPeptone
Drug discovery platform designing small-molecule candidates for hard-to-treat cancers and neurodegenerative disease targetsNew on EvolcPetagene
Genomic data compression, cloud access and encryption software for genomics researchers and bioinformatics teamsNew on EvolcPheno Therapeutics
Develops GPR17-targeting neuroprotective therapeutics for patients with multiple sclerosis and other neurological disordersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Cookie namedistinctive cookie name
- Cookie namedistinctive cookie name
- Cookie namedistinctive cookie name
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.